4//SEC Filing
Downs Christopher 4
Accession 0001683168-21-000448
CIK 0001729427other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:00 PM ET
Size
5.5 KB
Accession
0001683168-21-000448
Insider Transaction Report
Form 4
Downs Christopher
Chief Financial Officer
Transactions
- Award
Option to purchase common stock (right to buy)
2021-02-05+131,000→ 431,000 totalExercise: $3.36Exp: 2031-02-05→ Common Stock (131,000 underlying)
Footnotes (2)
- [F1]The stock options set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date and are subject to the grantee's continued service to the Company on each vesting date.
- [F2]The stock options were issued in connection with the reporting person's employment with the Company.
Documents
Issuer
CNS Pharmaceuticals, Inc.
CIK 0001729427
Entity typeother
Related Parties
1- filerCIK 0001705978
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 5:00 PM ET
- Size
- 5.5 KB